Home > Research > Publications & Outputs > A strategy for designing inhibitors of α-synucl...

Research

Links

Text available via DOI:

View graph of relations

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. / El-Agnaf, Omar M. A.; Paleologou, Katerina E.; Greer, Brett et al.
In: FASEB Journal, Vol. 18, No. 11, 08.2004, p. 1315-1317.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

El-Agnaf, OMA, Paleologou, KE, Greer, B, Abogrein, AM, King, J, Salem, SA, Fullwood, NJ, Benson, FE, Hewitt, R, Ford, KJ, Martin, F, Harriott, P, Cookson, MR & Allsop, D 2004, 'A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.', FASEB Journal, vol. 18, no. 11, pp. 1315-1317. https://doi.org/10.1096/fj.03-1346fje.

APA

El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F., Harriott, P., Cookson, M. R., & Allsop, D. (2004). A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB Journal, 18(11), 1315-1317. https://doi.org/10.1096/fj.03-1346fje.

Vancouver

El-Agnaf OMA, Paleologou KE, Greer B, Abogrein AM, King J, Salem SA et al. A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB Journal. 2004 Aug;18(11):1315-1317. doi: 10.1096/fj.03-1346fje.

Author

El-Agnaf, Omar M. A. ; Paleologou, Katerina E. ; Greer, Brett et al. / A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. In: FASEB Journal. 2004 ; Vol. 18, No. 11. pp. 1315-1317.

Bibtex

@article{827da61332d64f079d5d6cfcb15506b7,
title = "A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.",
author = "El-Agnaf, {Omar M. A.} and Paleologou, {Katerina E.} and Brett Greer and Abogrein, {Abdulmawala M.} and Jennifer King and Salem, {Sultan A.} and Fullwood, {Nigel J.} and Benson, {Fiona E.} and Rebecca Hewitt and Ford, {Kirstie J.} and Frank Martin and Patrick Harriott and Cookson, {Mark R.} and David Allsop",
year = "2004",
month = aug,
doi = "10.1096/fj.03-1346fje.",
language = "English",
volume = "18",
pages = "1315--1317",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "11",

}

RIS

TY - JOUR

T1 - A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

AU - El-Agnaf, Omar M. A.

AU - Paleologou, Katerina E.

AU - Greer, Brett

AU - Abogrein, Abdulmawala M.

AU - King, Jennifer

AU - Salem, Sultan A.

AU - Fullwood, Nigel J.

AU - Benson, Fiona E.

AU - Hewitt, Rebecca

AU - Ford, Kirstie J.

AU - Martin, Frank

AU - Harriott, Patrick

AU - Cookson, Mark R.

AU - Allsop, David

PY - 2004/8

Y1 - 2004/8

U2 - 10.1096/fj.03-1346fje.

DO - 10.1096/fj.03-1346fje.

M3 - Journal article

VL - 18

SP - 1315

EP - 1317

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 11

ER -